2-(6-Methylpyridin-2-yl)acetamide

Catalog No.: 
ACVOPP575
CAS No.: 
51444-35-0
Molecular Formula: 
C8H10N2O
Molecular Weight: 
150.18
2-(6-Methylpyridin-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(6-Methylpyridin-2-yl)acetamide
IUPAC Name2-(6-methylpyridin-2-yl)acetamide
Molecular FormulaC8H10N2O
Molecular Weight150.18
SMILESO=C(N)CC1=NC(C)=CC=C1
InChI KeyVJWOVBIKJFPXNI-UHFFFAOYSA-N
Synonym2-(6-Methylpyridin-2-yl)acetaMide;2-Pyridineacetamide, 6-methyl-
CAS No.51444-35-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVOPP575 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZMHE189 route compound structure diagram
    ACZMHE18992917-49-2In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACVOPP575 route product structure diagram
    ACVOPP57551444-35-0
Inquiry

2. ACVOPP575 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYNPX179 route compound structure diagram
    ACYNPX17958532-56-2In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACVOPP575 route product structure diagram
    ACVOPP57551444-35-0
Inquiry

3. ACVOPP575 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXGZD384 route compound structure diagram
    ACXGZD3845552-83-0In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACVOPP575 route product structure diagram
    ACVOPP57551444-35-0
Inquiry

Comments (0)